Order Now IMFINZI Durvalumab 120 mg Injection Online – GlobMedIndia Exporter Saudi Arabia - Riyadh, Jeddah, Mecca, Medina, Dammam, USA, UK, UAE Australia, Europe, United Kingdom, United States, Cambridge, London, Morocco, Indonesia, Chile, Peru, Ethiopia, Romania, China, Japan, Russia, Ukraine, Dubai, United Arab Emirates, South Korea, Africa, Thailand, Vietnam, Middle East, and Southeast Asian countries.

💉 IMFINZI (Durvalumab 120 mg Injection)

IMFINZI is an advanced immunotherapy medicine used in the treatment of various cancers. It contains Durvalumab, a monoclonal antibody that enhances the body’s immune system to detect and destroy cancer cells more effectively.

Developed by AstraZeneca, IMFINZI belongs to a class of drugs called immune checkpoint inhibitors, specifically targeting the PD-L1 protein.

🧪 Composition & Content

• Active Ingredient: Durvalumab
• Strength: 120 mg per vial
• Form: Sterile solution for intravenous infusion
• Mechanism:
  Durvalumab blocks PD-L1 interaction with PD-1 and CD80 receptors, restoring T-cell response against tumor cells.

⚙️ How It Works

Cancer cells often evade the immune system by expressing PD-L1. Durvalumab inhibits this pathway, allowing immune cells (T-cells) to:

• Recognize cancer cells
• Attack and destroy them effectively

🩺 Uses & Indications

IMFINZI is widely used in the treatment of:

• Non-Small Cell Lung Cancer (NSCLC)
• Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
• Biliary Tract Cancer (in combination therapy)
• Hepatocellular Carcinoma (liver cancer, in some regimens)

💊 Dosage & Administration

• Route: Intravenous (IV) infusion
• Typical Dose:
• 10 mg/kg every 2 weeks OR
• Fixed dose (e.g., 1500 mg every 4 weeks depending on indication)
• Administration Time: 60 minutes infusion
• Supervision: Must be given by a qualified oncologist in a clinical setting

⚠️ Dosage varies based on patient condition, weight, and treatment protocol.

🧬 Treatment Benefits & Advantages

• Targets cancer through immune system activation
• Improves survival rates in lung cancer patients
• Less toxic compared to traditional chemotherapy
• Can be combined with other therapies
• Long-lasting response in some patients

🧊 Storage Conditions

• Store at 2°C to 8°C (refrigerated)
• Do not freeze or shake
• Keep in original packaging to protect from light
• Use immediately after dilution or as directed

🇮🇳 Alternative Indian Brands / Biosimilars

Currently, Durvalumab biosimilars are limited in India due to patent and regulatory factors. However, oncologists may consider alternative immunotherapy molecules such as:

• Pembrolizumab (Keytruda alternatives)
• Nivolumab (Opdivo alternatives)
• Atezolizumab

👉 These are not exact substitutes but belong to the same PD-1/PD-L1 inhibitor class.

Buy IMFINZI Durvalumab 120 mg Injection Online – GlobMedIndia Exporter